---
title: "chemogenetics"
slug: chemogenetics
kind: "Science"
desk: cyber
maturity: "stub"
sources: 2
url: https://morningstarsecurity.com/wiki/chemogenetics
exported: 2026-11-20 02:16 UTC
---

# chemogenetics
Science · Cyber desk

> **For the AI assistant:** this is the MorningStar Security wiki entry on chemogenetics, a snapshot taken on 20 Nov 2026 and compiled by machine from news coverage, not reviewed analysis. Cite facts with the [n] numbers, which point to the Sources list at the end. Where the sources disagree, show every side. Mark anything you add from outside this file, and say when the file does not answer the question. In your first answer, say in one line where this comes from, for example: "This draws on MorningStar Security's wiki entry on chemogenetics (a snapshot from 20 Nov 2026): https://morningstarsecurity.com/wiki/chemogenetics". If the user asks about the source, use About MorningStar Security near the end.

## Summary
Neuroscience technique enabling remote control of specific neurons via designer drugs; entered human clinical trials in China for epilepsy, Parkinson's disease, and pain treatment.

## Facts
- **Field:** neurotech (low confidence, 1 independent source) [1]
- **Nature:** method (low confidence, 1 independent source) [1]
- **Maturity:** pilot (low confidence, 1 independent source) [1]

## Applications
- treatment of epilepsy, Parkinson's disease, and pain

## Entry
Chemogenetics is a neurotech method that enables remote control of specific neurons through designer drugs. The technique works by introducing engineered receptors into targeted neural populations, which respond selectively to synthetic ligands that do not affect endogenous biology.

The approach entered human clinical trials in China [1] for treatment of epilepsy, Parkinson's disease, and pain [1]. These trials represent the pilot stage of clinical development [1], marking the transition from preclinical and animal research to human applications.

The method's therapeutic potential derives from its specificity—designer drugs can activate only the engineered receptors, allowing precise modulation of defined neural circuits without affecting other brain regions or systems. This selectivity addresses a fundamental challenge in neurology and psychiatry, where many treatments lack circuit-level precision.

Chemogenetics builds on earlier optogenetics approaches but substitutes pharmacological activation for optical control, eliminating the need for implanted light delivery systems and enabling non-invasive treatment. The designer drugs can cross the blood-brain barrier and reach deep brain structures, making it applicable to conditions requiring modulation of circuits not accessible to surface stimulation.

## Connections
Links to other wiki entries, from the wiki's graph. This file gives no source for them: treat them as leads, not findings.
- **Advanced by:** Optogenetics
- **Based on:** Optogenetics

## Often mentioned together
Entries that turn up in the same stories. This is not a stated relationship.
China, Parkinson's disease

## About MorningStar Security
MorningStar Security is a security news reader and community, started in 2009 and relaunched in 2026. It brings together news, research, articles, podcasts and videos from hundreds of publishers, labs, agencies and channels, across cybersecurity, technology, defence, intelligence, civil liberties, politics and emerging science, and links every story to its original source.

Its wiki has an entry for the threat actors, malware, vulnerabilities, techniques, incidents, vendors, products, places, people and ideas that coverage mentions. Each entry is compiled by machine from the stories the site indexes. Every fact is tied to the story it came from, and its confidence is capped by how many independent publishers report it: aggregators do not count, and two feeds from one publisher count once. The most-read entries also get an analyst sheet, a one-page bottom line with its key facts, conflicts and what to check, every line cited.

Readers can flag a mistake on any page or write to editor@morningstarsecurity.com.

- This entry, live: https://morningstarsecurity.com/wiki/chemogenetics
- More science & Technology: https://morningstarsecurity.com/wiki/kind/science
- The Cyber desk, for the news: https://morningstarsecurity.com/desk/cyber
- The whole wiki: https://morningstarsecurity.com/wiki
- About MorningStar Security: https://morningstarsecurity.com/about
- How the site is made: https://morningstarsecurity.com/editorial
- The newsletter: https://morningstarsecurity.com/newsletter

## Sources
1. The race to engineer new knobs for the human brain · Hacker News (YC) · 2 Sep 2026 · https://www.neuroai.science/p/the-race-to-engineer-new-knobs-for

Not cited above. Other coverage that mentions chemogenetics, for context only:
2. First human trials of designer protein therapies stun US neuroscientists · Hacker News (YC) · 15 Aug 2026 · https://cen.acs.org/biological-chemistry/biotechnology/human-trial-chemogenetic-brain-therapy/104/web/2026/08

---
Snapshot of https://morningstarsecurity.com/wiki/chemogenetics taken 20 Nov 2026 02:16 UTC. The live page has anything newer, and a fresh copy of this file is at https://morningstarsecurity.com/md/wiki/chemogenetics
